Genelux Corporation (NASDAQ: GNLX) Stock Information | RedChip

Genelux Corporation (NASDAQ: GNLX) Listen to this Section


$2.03
-0.1000 ( -4.69% ) 60.6K

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Market Data


Open


$2.03

Previous close


$2.13

Volume


60.6K

Market cap


$69.39M

Day range


$2.02 - $2.16

52 week range


$1.60 - $30.44

Insider Ownership Transactions

Total Amount Purchased: -242,813.00 | $ -492,910.39

Date Type Amount Purchased Purchaser
2023-09-12 Sale -65000.00 Cappello Joseph
2023-09-12 Sale -65000.00 Yu Yong
2023-09-12 Sale -40000.00 Samuelson Doug
2023-09-12 Sale -40000.00 Ryder Sean
2023-09-11 Sale -9938.00 Szalay Aladar
2023-08-30 Sale -19800.00 Yu Yong
2023-08-22 Sale -328.00 Ryder Sean
2023-08-22 Sale -1297.00 Samuelson Doug
2023-08-22 Sale -935.00 Smalling Ralph
2023-08-22 Sale -515.00 Jewett Caroline

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Sep 21, 2023
4 Insider transactions 1 Sep 21, 2023
4 Insider transactions 1 Sep 20, 2023
4 Insider transactions 1 Sep 18, 2023
4 Insider transactions 1 Sep 18, 2023
4 Insider transactions 1 Sep 15, 2023
4 Insider transactions 1 Sep 15, 2023
4 Insider transactions 1 Sep 15, 2023
8-k 8K-related 12 Sep 14, 2023
4 Insider transactions 1 Sep 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.